Becker's Healthcare December 8, 2017
Laura Dyrda

CVS Health announced plans to acquire Aetna earlier this week for $69 billion, and leaders across healthcare are examining what the deal could mean for the industry going forward.

The total effect of the deal on patients, healthcare providers and pharmacy prices is up for debate. If approved, healthcare is looking at a brave new world of healthcare delivery and consumerism.

Here, industry leaders respond to key questions about the deal and provide insight into what could happen next, and how healthcare providers should prepare.

Note: Responses were edited lightly for clarity and length.

Question: Are consumers winners or losers in this deal?

Herman Sanchez. Managing Partner of Trinity Partners (Chicago): “Following hot on the heels of Amazon looking to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Payer, Retail care
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Weekly HCRE Briefing: AdventHealth to Acquire Two CHS Hospitals in FL | Kaiser Acquiring ASCs and MOBs

Share This Article